Vygon Acquires Stiletto Extended-Dwell Catheter

Vygon has acquired the Stiletto^® extended-dwell catheter and its patented SlipStream™ insertion technology from Avia Vascular, marking its entry into the fast-growing extended-dwell catheter segment. Financial details of the transaction were not disclosed.

The Stiletto Extended Dwell Catheter (EDC) is a sterile, peripherally inserted, single-use device designed for mid-duration therapies of less than 28 days. Its SlipStream™ system replaces the traditional Seldinger technique, eliminating guidewires and reducing procedural steps.

Strengthening U.S. Market Position
The acquisition supports Vygon’s strategy to accelerate growth in the United States, the world’s largest market for midline and extended-dwell catheters. North America accounted for over 40% of global midline catheter revenue in 2024, with the broader segment estimated at more than $3 billion and projected to grow at a CAGR of 6–9% through 2030.

By integrating Stiletto into its portfolio, Vygon expands its vascular access offering, which now spans:

SlipStream™ Technology: Simplified Insertion
SlipStream™ is designed to simplify extended-dwell catheter placement by removing the need for guidewires and minimizing insertion steps. According to Vygon, this approach offers:

Company leadership stated that the technology closes a strategic gap in Vygon’s vascular access portfolio and aligns with its focus on delivering clinically efficient and patient-centered solutions.

This acquisition reinforces Vygon’s position in vascular management while strengthening its presence in high-growth markets, particularly the U.S., where demand for mid-term venous access solutions continues to expand.

www.vygon.com